Integrated CRO-CDMO partnerships promise to streamline drug development by bringing development, manufacturing, and clinical execution together under one strategic framework. But integration isn’t achieved simply by combining services. It depends on connecting decisions, processes, and teams across the development lifecycle.

Clinical supply chain is the function that makes this possible.

Serving as the bridge between drug development and clinical operations, clinical supply chain connects manufacturing, quality, regulatory, packaging, labeling, distribution, and clinical execution into a coordinated strategy. It helps ensure information, materials, and decisions move efficiently across functions, reducing operational risk and supporting more predictable study execution.

In this webinar, we’ll examine how clinical supply chain connects development and clinical operations to enable coordinated execution across integrated CRO-CDMO programs. Using the framework of people, processes, and systems, we’ll explore the operational capabilities that help sponsors strengthen collaboration, reduce risk, and realize the full value of an integrated partnership.

Attendees will learn:

• The role clinical supply chain plays in connecting development, manufacturing, and clinical operations.
• How embedding clinical supply chain strategy early improves alignment, reduces operational risk, and increases agility throughout study execution.
• Why people, processes, and systems are essential to transforming integrated services into integrated execution.